In this webinar, Dr. Rita Cruz will introduce Ingenza’s inGenius™ platform, which plays a pivotal role in speeding up a candidate’s journey to the clinic.
bioMérieux will assess AST/AES results and validate against evolving global antimicrobial susceptibility data collected through the JMI-led SENTRY program.
Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.